4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-009899
President and CEO sold 21,000 shares at $15.16 ($318,360)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2026-03-16 | Option exercise 10b5-1 | +15,000 | $5.40 | $81,000 | 2,133,777 | D: show line 1 in the form |
| Grossman Adam S President and CEO | 2026-03-16 | Sale 10b5-1 | −15,000 | $15.16 | $227,400 | 2,118,777 | D: show line 2 in the form |
| Grossman Adam S President and CEO | 2026-03-16 | Sale 10b5-1 | −6,000 | $15.16 | $90,960 | 2,112,777 | D: show line 3 in the form |
| Open-market sales · 21,000 sh · avg $15.16 · $318,360 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2026-03-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 690,950 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…